A61K31/17 - page 3 - CPC Classification Index

#601

20150203448

2015-07-23

Aryloxyurea compound and pest control agent

#602

20150202179

2015-07-23

FATTY ACID DERIVATIVES FOR USE IN A METHOD OF TREATING DEPRESSION AND ASSOCIATED CONDITIONS

#603

20150202170

2015-07-23

Immune cell activation inhibitor and use thereof

#604

20150157590

2015-06-11

COCRYSTALS OF (N,N-DIETHYLCARBAMOYL)METHYL METHYL (2E)BUT-2-ENE-1,4-DIOATE

#605

20150157586

2015-06-11

PENETRATING PHARMACEUTICAL FOAM

#606

20150157560

2015-06-11

Methods of intravenous administration of glyburide

#607

20150150878

2015-06-04

Methods For Inhibiting Viruses By Targeting Cathepsin-L Cleavage Sites In The Viruses' Glycoproteins

#608

20150148395

2015-05-28

Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators

#609

20150148301

2015-05-28

Inhibitors of the activity of complex (III) of the mitochondrial electron transport chain and use thereof

#610

20150140092

2015-05-21

COATED DRUG DELIVERY FORMULATIONS

#611

20150132408

2015-05-14

Sorafenib derivatives as p21 inhibitors

#612

20150125509

2015-05-07

TREATMENT OF FISH POPULATIONS WITH LUFENURON

#613

20150118311

2015-04-30

Highly penetrative nanocarriers for treatment of CNS disease

#614

20150111911

2015-04-23

Treating Bax(Δ)2-positive cancer with chemotherapies targeting caspase 8

#615

20150110713

2015-04-23

METHOD AND COMPOSITION FOR TREATING CANCER

#616

20150087611

2015-03-26

Multi-step connective tissue stabilization method and stabilized tissue formed thereby

#617

20150087610

2015-03-26

Method of Modifying Fertility

#618

20150079177

2015-03-19

METHODS AND COMPOSITIONS FOR TREATING PROLIFERATIVE DISEASES

#619

20150072025

2015-03-12

Sodium nitrite-containing pharmaceutical compositions

#620

20150072024

2015-03-12

Sodium nitrite-containing pharmaceutical compositions

#621

20150065453

2015-03-05

Combination of an oxidant and a photoactivator for the healing of wounds

#622

20150064126

2015-03-05

Use of chitosans for the treatment of nail inflammatory diseases

#623

20150057331

2015-02-26

Cellular targets for HIV infection

#624

20150051288

2015-02-19

Methods and Compositions for Treatment of Autism

#625

20150044184

2015-02-12

SIRT1 inhibitors and stem cell rejuvenation

#626

20150037390

2015-02-05

Self-assembling bis-urea compounds for drug delivery

#627

20150024053

2015-01-22

Topical wound treatment method and composition

#628

20150017267

2015-01-15

Treatment of inflammatory disorders in non-human mammals

#629

20140371253

2014-12-18

Cyclopamine analogs

#630

20140364387

2014-12-11

Methods and systems for modulating hormones and related methods, agents and compositions

#631

20140350106

2014-11-27

Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same

#632

20140348926

2014-11-27

FORMULATION AND METHOD FOR INCREASING ORAL BIOAVAILABILITY OF DRUGS

#633

20140348824

2014-11-27

Predictive biomarker of survival in the treatment of renal cell carcinoma

#634

20140323423

2014-10-30

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#635

20140322326

2014-10-30

Particles comprising a releasable dopant therein

#636

20140322304

2014-10-30

Compositions and methods relating to proliferative diseases

#637

20140301979

2014-10-09

ANTI-ARENAVIRAL COMPOUNDS

#638

20140275254

2014-09-18

Pharmaceutical composition for the treatment of fungal infections

#639

20140256684

2014-09-11

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

#640

20140248374

2014-09-04

COMPOSITIONS AND MULTI-STEP METHODS OF USING THE SAME FOR THE TREATMENT OF JELLYFISH STINGS

#641

20140234257

2014-08-21

Oncolytic viruses and methods for treating neoplastic disorders

#642

20140227199

2014-08-14

Penetrating pharmaceutical foam

#643

20140187639

2014-07-03

Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof

#644

20140186375

2014-07-03

Immuno gene therapy for treatment of cancer and hyperproliferative diseases

#645

20140179778

2014-06-26

COCRYSTALS OF (N,N-DIETHYLCARBAMOYL)METHYL METHYL (2E)BUT-2-ENE-1,4-DIOATE

#646

20140171504

2014-06-19

Methods of Treating Sickle Cell Disease and Related Disorders Using Fumaric Acid Esters

#647

20140171313

2014-06-19

Pesticidal compositions and processes related thereto

#648

20140171312

2014-06-19

Pesticidal compositions and processes related thereto

#649

20140171309

2014-06-19

Pesticidal compositions and processes related thereto

#650

20140171308

2014-06-19

Pesticidal compositions and processes related thereto

#651

20140162996

2014-06-12

Modulators of development of adipocyte and cancer cells

#652

20140147415

2014-05-29

TREATMENT OF MASTOCYTOSIS WITH MASITINIB

#653

20140134112

2014-05-15

Topical pharmaceutical foam composition

#654

20140107142

2014-04-17

Methods of use of cyclopamine analogs

#655

20140094418

2014-04-03

PALATABLE DUCTILE CHEWABLE VETERINARY COMPOSITION

#656

20140088056

2014-03-27

CARDIAC GLYCOSIDES ARE POTENT INHIBITORS OF INTERFERON-BETA GENE EXPRESSION

#657

20140079804

2014-03-20

COMPOSITIONS AND METHODS FOR TREATMENT OF INFECTIONS

#658

20140073613

2014-03-13

Topical formulation for treatment of hyperkeratotic skin

#659

20140066514

2014-03-06

Veterinary compositions for controlling ecto- and endoparasites in bovines, use of these compositions, use of IGR substances associated with microminerals, method for controlling ecto- and endoparasites in bovines and kit

#660

20140066483

2014-03-06

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

#661

20130345164

2013-12-26

TREATMENTS FOR CELLULAR PROLIFERATIVE DISORDERS AND IDENTIFICATION THEREOF

#662

20130338178

2013-12-19

SIRTUIN MODULATORS AS INHIBITORS OF CYTOMEGALOVIRUS

#663

20130281515

2013-10-24

Cationic bis-urea compounds as effective antimicrobial agents

#664

20130267550

2013-10-10

Compounds and methods for treating aberrant adrenocartical cell disorders

#665

20130267441

2013-10-10

Biomarker and uses thereof in diagnosis, treatment of autism

#666

20130261120

2013-10-03

Substituted N-(2-arylamino)aryl sulfonamide-containing combinations

#667

20130245231

2013-09-19

Ophthalmic composition comprising ws-12 and methods to treat xerophthalmia

#668

20130245037

2013-09-19

Stabilization of Hypoxia Inducible Factor (HIF) Alpha

#669

20130231479

2013-09-05

Aryloxyurea compound and pest control agent

#670

20130225642

2013-08-29

Pharmaceutical composition for prevention and treatment of amyotrophic lateral sclerosis

#671

20130195796

2013-08-01

Inhibitors and methods of inhibiting bacterial and viral pathogens

#672

20130190495

2013-07-25

Compositions and methods of treatment of cancer

#673

20130190405

2013-07-25

Methods and use of compounds that bind to Her2/neu receptor complex

#674

20130184293

2013-07-18

COMPOSITIONS AND METHODS FOR TREATING DIABETES AND NEUROPSYCHOLOGICAL DYSFUNCTION

#675

20130178446

2013-07-11

METHOD FOR DECREASING SEBUM PRODUCTION

#676

20130172425

2013-07-04

Compositions and methods for treating hoof diseases

#677

20130158067

2013-06-20

TRPV1 antagonists

#678

20130158036

2013-06-20

N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

#679

20130158022

2013-06-20

Acrylamide compounds and use thereof for inhibiting apoptosis

#680

20130156816

2013-06-20

METHODS AND COMPOSITIONS FOR USE IN AQUACULTURE

#681

20130149314

2013-06-13

p19Arf, HMGA2 and MDM2 For Use in the Diagnosis and Treatment of Aberrant Cell Growth

#682

20130137725

2013-05-30

METHOD OF TREATING SENSORIMOTOR DISORDERS WITH ALPHA-2 ADRENERGIC RECEPTOR AGONISTS

#683

20130137650

2013-05-30

Methods of treatment using combination therapy

#684

20130129840

2013-05-23

COMBINATION THERAPY USING A RUTHENIUM COMPLEX

#685

20130123203

2013-05-16

Methods and compositions for treatment of autism

#686

20130108582

2013-05-02

Methods of use of cyclopamine analogs

#687

20130085461

2013-04-04

Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof

#688

20130072491

2013-03-21

Prophylactic or therapeutic agent for diabetes or obesity

#689

20130052263

2013-02-28

PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE

#690

20130045941

2013-02-21

Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases

#691

20130045172

2013-02-21

USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS

#692

20130035397

2013-02-07

Anti-Viral Compounds

#693

20130023561

2013-01-24

Facially amphiphilic polymers and oligomers and uses thereof

#694

20130018014

2013-01-17

New class of therapeutics that enhance small molecule diffusion

#695

20130012590

2013-01-10

Subcutaneous fat reduction

#696

20130005803

2013-01-03

USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS

#697

20130005778

2013-01-03

Urethanes, ureas, amidines and related inhibitors of factor Xa

#698

20120329841

2012-12-27

Treating cancer with desthiazolyl ritonavir

#699

20120328709

2012-12-27

Methods of dissolving blood clots and the like

#700

20120322877

2012-12-20

(bis)urea and (bis)thiourea compounds as epigenic modulators of lysine-specific demethylase 1 and methods of treating disorders

#701

20120308519

2012-12-06

Anti-arenaviral compounds

#702

20120302942

2012-11-29

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, Alzheimer'S disease, sleep disorders, Parkinson'S disease, AIDS, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#703

20120289552

2012-11-15

Aryl ureas with angiogenesis inhibiting activity

#704

20120283302

2012-11-08

SCCA-1 PRODUCTION INHIBITOR HAVING A CARBOXAMIDE DERIVATIVE AND/OR A SALT THEREOF AS AN ACTIVE INGREDIENT

#705

20120283298

2012-11-08

METHODS FOR TREATING MEMORY IMPAIRMENT

#706

20120277693

2012-11-01

Method and apparatus for improving the appearance of nails affected by onychomycosis through the topical application of an aqueous solution containing boric acid and camphor or other terpenes

#707

20120276121

2012-11-01

Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases

#708

20120270878

2012-10-25

INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS

#709

20120264726

2012-10-18

Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (MSM)

#710

20120263657

2012-10-18

Promoting Whole Body Health

#711

20120244226

2012-09-27

TREATMENT COMPOSITION AND METHOD

#712

20120238624

2012-09-20

Formulations for the treatment of pain

#713

20120207827

2012-08-16

Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis

#714

20120207793

2012-08-16

Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications

#715

20120202814

2012-08-09

COMPOUNDS WITH DDX3 INHIBITORY ACTIVITY AND USES THEREOF

#716

20120196937

2012-08-02

Treatment of ophthalmic disorders using urea

#717

20120195951

2012-08-02

Therapeutic Inhibitor of Vascular Smooth Muscle Cells

#718

20120178816

2012-07-12

Carbamide peroxide treatments for the reproductive tract

#719

20120177743

2012-07-12

Combinations and modes of administration of therapeutic agents and combination therapy

#720

20120156280

2012-06-21

Myeloid derived suppressor cell inhibiting agents

#721

20120141578

2012-06-07

Compositions and methods relating to proliferative diseases

#722

20120136033

2012-05-31

Small Molecule Antagonists of Phosphatidylinositol-3,4,5-Triphosphate (PIP3) and Uses Thereof

#723

20120130144

2012-05-24

TREATMENT OF LUNG CANCER WITH A NITROBENZAMIDE COMPOUND IN COMBINATION WITH A GROWTH FACTOR INHIBITOR

#724

20120129801

2012-05-24

BLOOD PARASITICIDE

#725

20120129800

2012-05-24

Agent for preventing and treating pityriasis versicolor

#726

20120128598

2012-05-24

Topical Pharmaceutical Foam Composition

#727

20120121707

2012-05-17

Tolbutamide Particle And Preparing Method Thereof And Method Of Reducing A Blood Glucose

#728

20120115877

2012-05-10

Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating Cancer

#729

20120114612

2012-05-10

Oncolytic viruses and methods for treating neoplastic disorders

#730

20120101080

2012-04-26

Composition for treatment of tuberculosis

#731

20120077834

2012-03-29

Methods of use of cyclopamine analogs

#732

20120076859

2012-03-29

Targeted Lung Delivery of Citrulline and/or Another Nitric Oxide Precursor and a Method for Treatment of Pulmonary Deficiency of Nitric Oxide in Cystic Fibrosis and Other Pulmonary Diseases

#733

20120071448

2012-03-22

S1P3 Receptor Inhibitors for Treating Conditions of the Eye

#734

20120059055

2012-03-08

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

#735

20120058965

2012-03-08

Methods and systems for modulating hormones and related methods, agents and compositions

#736

20120058123

2012-03-08

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

#737

20120046296

2012-02-23

Palatable ductile chewable veterinary composition

#738

20120041031

2012-02-16

Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists

#739

20120027864

2012-02-02

Coated drug delivery formulations

#740

20120016033

2012-01-19

Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof

#741

20120010178

2012-01-12

METHODS AND COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISORDERS

#742

20120004245

2012-01-05

COMPOUNDS FOR THE TREATMENT OF POSTERIOR SEGMENT DISORDERS AND DISEASES

#743

20120003206

2012-01-05

Liquid, aqueous pharmaceutical compositions of factor VII polypeptides

#744

20110313006

2011-12-22

PHARMACEUTICAL COMPOSITION OF LEVAMLODIPINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND β RECEPTOR BLOCKING AGENT, AND USE THEREOF

#745

20110312920

2011-12-22

Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same

#746

20110300221

2011-12-08

Therapeutic Inhibitor of Vascular Smooth Muscle Cells

#747

20110294878

2011-12-01

Inhibitors of dimethylarginine dimethylaminohydrolase

#748

20110280807

2011-11-17

Methods and Models for Stress-Induced Analgesia

#749

20110275561

2011-11-10

Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

#750

20110269831

2011-11-03

Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

#751

20110263478

2011-10-27

SUR1 INHIBITORS FOR THERAPY

#752

20110251149

2011-10-13

Methods and low dose regimens for treating red blood cell disorders

#753

20110237663

2011-09-29

Method for treating Philadelphia-negative myeloproliferative syndromes

#754

20110230555

2011-09-22

Enzyme Inhibitors and the Use Thereof

#755

20110230509

2011-09-22

METHODS OF USE FOR CYCLOPAMINE ANALOGS

#756

20110224599

2011-09-15

Combination of an oxidant and a photoactivator for the healing of wounds

#757

20110218482

2011-09-08

Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin

#758

20110218231

2011-09-08

Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases

#759

20110200554

2011-08-18

THERAPEUTIC AGENT FOR HEPATITIS C

#760

20110200544

2011-08-18

UREA-BASED FILM-FORMING SOLUTION FOR TREATING NAIL PSORIASIS

#761

20110195046

2011-08-11

ERYTHROPOIETIN AMELIORATES CHEMOTHERAPY-INDUCED TOXICITY IN VIVO

#762

20110178046

2011-07-21

Methods for treating glioblastoma

#763

20110166223

2011-07-07

METHODS OF INHIBITING FGFR3 SIGNALING

#764

20110166178

2011-07-07

Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase

#765

20110166145

2011-07-07

Stabilization of hypoxia inducible factor (HIF) alpha

#766

20110160265

2011-06-30

METHOD OF TREATING MOTOR DISORDERS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS

#767

20110152263

2011-06-23

COMPOSITION AND METHOD FOR INHIBITING NOROVIRUS INFECTION

#768

20110135580

2011-06-09

Novel Medicament Combinations for the Treatment of Respiratory Diseases

#769

20110130391

2011-06-02

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

#770

20110123600

2011-05-26

Use of alkylureas for treating acne

#771

20110118199

2011-05-19

USE OF CNS PENETRATING ANTICANCER COMPOUNDS FOR THE TREATMENT OF PROTOZOAL DISEASES

#772

20110117222

2011-05-19

Pharmaceutical Compositions for the Treatment of Warts

#773

20110110958

2011-05-12

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEOPLASIA

#774

20110104308

2011-05-05

Treatment For Diseases Relying On Discovery That Thioredoxin Mediates Nitric Oxide

#775

20110086113

2011-04-14

CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (E.G. SERM OR ALKYLATING AGENTS)

#776

20110083692

2011-04-14

METHOD AND APPARATUS FOR IMPROVING THE APPEARANCE OF NAILS AFFECTED BY ONYCHOMYCOSIS THROUGH THE TOPICAL APPLICATION OF HIGHLY CONCENTRATED OR SUPERSATURATED BORIC ACID

#777

20110071164

2011-03-24

ERG CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS

#778

20110065760

2011-03-17

COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF

#779

20110060042

2011-03-10

External preparation for skin

#780

20110053880

2011-03-03

Composition for treatment of tuberculosis

#781

20110039886

2011-02-17

Enhanced erythropoiesis and iron metabolism

#782

20110039852

2011-02-17

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#783

20110038950

2011-02-17

Enhanced erythropoiesis and iron metabolism

#784

20110038936

2011-02-17

SYSTEM AND METHOD FOR ELECTROSPUN DRUG LOADED BIODEGRADABLE CHEMOTHERAPY APPLICATIONS

#785

20110034494

2011-02-10

REVERSIBLE INHIBITION OF SPERM RECEPTOR SYNTHESIS FOR CONTRACEPTION

#786

20110028559

2011-02-03

SUBSTITUTED FLUOROETHYL UREAS AS ALPHA 2 ADRENERGIC AGENTS

#787

20110020477

2011-01-27

ORAL PREPARATION, INJECTION PREPARATION, EXTERNAL SKIN PREPARATION AND COSMETIC METHOD FOR PREVENTING OR IMPROVING WRINKLES

#788

20110015195

2011-01-20

Aryl ureas with angiogenisis inhibiting activity

#789

20100331362

2010-12-30

Treatment method for anemia

#790

20100317733

2010-12-16

USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS

#791

20100316575

2010-12-16

MODULATING BODY WEIGHT

#792

20100311701

2010-12-09

Pharmaceutical Co-Crystal Compositions

#793

20100292177

2010-11-18

Methods of treatment using combination therapy

#794

20100286222

2010-11-11

USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS

#795

20100286180

2010-11-11

Methods of use of cyclopamine analogs

#796

20100284938

2010-11-11

Penetrating pharmaceutical foam

#797

20100280044

2010-11-04

Enhanced erythropoiesis and iron metabolism

#798

20100278941

2010-11-04

Enhanced erythropoiesis and iron metabolism

#799

20100274051

2010-10-28

Inflammatory cytokine release inhibitor

#800

20100273838

2010-10-28

STABLE TOPICAL COMPOSITIONS FOR 1,2,4-THIADIAZOLE DERIVATIVES

#801

20100273834

2010-10-28

TREATMENT OF ONYCHOMYCOSIS AND RELATED COMPOSITIONS INCLUDING UREA

#802

20100267807

2010-10-21

Alleviating neuropathic pain with EETs and sEH inhibitors

#803

20100267620

2010-10-21

METHODS FOR SLOWING SENESCENCE AND TREATING AND PREVENTING DISEASES ASSOCIATED WITH SENESCENCE

#804

20100261796

2010-10-14

Use of Novel Compounds for IBD Treatment

#805

20100249064

2010-09-30

METHODS AND COMPOSITIONS FOR TREATING DISEASES AND CONDITIONS INVOLVING HIGHER MOLECULAR WEIGHT HYALURONAN

#806

20100240699

2010-09-23

Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists

#807

20100234454

2010-09-16

TREATMENT OF CNIDARIA INTOXICATION

#808

20100216852

2010-08-26

Methods for screening antimicrobial and antiviral compounds and uses thereof

#809

20100215746

2010-08-26

PREVENTION OF CISPLATIN INDUCED DEAFNESS

#810

20100204322

2010-08-12

METHOD OF TREATING AUTOIMMUNE DISEASES

#811

20100203172

2010-08-12

Sodium nitrite-containing pharmaceutical compositions

#812

20100183629

2010-07-22

ANTAGONISTS OF ENDOTHELIAL DIFFERENTIATION GENE SUBFAMILY 3 (EDG-3, S1P3) RECEPTORS FOR PREVENTION AND TREATMENT OF OCULAR DISORDERS

#813

20100173996

2010-07-08

SYNERGISTIC MIXTURES OF OPP AND DGH

#814

20100160445

2010-06-24

Synergistic Mixtures of OPP and DGH

#815

20100160273

2010-06-24

Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues

#816

20100151507

2010-06-17

Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same

#817

20100144761

2010-06-10

Antimicrobial Molecules For Treating Multi-Drug Resistant And Extensively Drug Resistant Strains Of Mycobacterium

#818

20100144736

2010-06-10

NOVEL BIPHENYL THIO-UREA DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS

#819

20100137451

2010-06-03

Compositions and methods for treating hoof diseases

#820

20100113601

2010-05-06

Method for decreasing sebum production

#821

20100104549

2010-04-29

Treatment of cancer with glufosfamide in patients not receiving insulin therapy

#822

20100099771

2010-04-22

USE OF COOLING AGENTS TO RELIEVE MILD OCULAR IRRITATION AND ENHANCE COMFORT

#823

20100093864

2010-04-15

ANTI-INFECTIVE THIOUREA COMPOUNDS

#824

20100074852

2010-03-25

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

#825

20100069423

2010-03-18

Use of Chk2 kinase inhibitors for cancer treatment

#826

20100063583

2010-03-11

USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF INFLAMMATORY VASCULAR DISEASES

#827

20100056453

2010-03-04

Liquid, aqueous pharmaceutical compositions of factor VII polypeptides

#828

20100048573

2010-02-25

Methods of inhibiting bacterial virulence and compounds relating thereto

#829

20100040561

2010-02-18

Penetrating pharmaceutical foam

#830

20100035930

2010-02-11

Urea and sulfamide derivatives as inhibitors of TAFIa

#831

20100029652

2010-02-04

Combination Therapy For Treating Hepatitis C Infections

#832

20100028348

2010-02-04

Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase

#833

20100022512

2010-01-28

Compositions of CHK1 inhibitors and cyclodextrin

#834

20100016395

2010-01-21

Ophthalmic compositions of parasympathetic stimulants and anti-inflammatories for use in the treatment of presbyopia

#835

20100008896

2010-01-14

Use of fenretinide or bioactive derivatives thereof and pharmaceutical compositions comprising the same

#836

20100004324

2010-01-07

Antimicrobial compounds and methods of use thereof

#837

20100003353

2010-01-07

Control of blood vessel physiology to treat skin disorders

#838

20100003346

2010-01-07

COMBINATION METHODS OF TREATING CANCER

#839

20100003302

2010-01-07

VASCULAR RESTENOSIS PREVENTING AGENT AND IMPLANTABLE INTRAVASCULAR DEVICE COATED THEREWITH

#840

20090324580

2009-12-31

Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases

#841

20090312273

2009-12-17

Compositions comprising dimethyl sulfoxide (DMSO)

#842

20090306212

2009-12-10

Compositions and methods for treating diabetes and neuropsychological dysfunction

#843

20090306149

2009-12-10

USE OF BIARYLCARBOXAMIES IN THE TREATMENT OF HEDGEHOG PATHWAY-RELATED DISORDERS

#844

20090275596

2009-11-05

Treatment of neurodegenerative disorders with thiourea compounds

#845

20090270452

2009-10-29

USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF SMOOTH MUSCLE DISORDERS

#846

20090247521

2009-10-01

SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION

#847

20090239850

2009-09-24

Kinase modulating compounds and uses thereof for treatment of cancer

#848

20090239841

2009-09-24

Diaryl Ureas as CB1 Antagonists

#849

20090233939

2009-09-17

TREATMENT OF AMM

#850

20090228996

2009-09-10

Means and Methods for influencing Interactions Between Dc-Sign and Dc-Sign Ligands

#851

20090220618

2009-09-03

PHARMACEUTICAL FORMULATIONS COMPRISING POLYANIONIC MATERIALS AND SOURCE OF HYDROGEN PEROXIDE

#852

20090216022

2009-08-27

Cyclopamine analogs

#853

20090215701

2009-08-27

Enhancement of iron chelation therapy

#854

20090197959

2009-08-06

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

#855

20090197916

2009-08-06

SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS

#856

20090192122

2009-07-30

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#857

20090176307

2009-07-09

Compounds, Compositions and Methods

#858

20090169630

2009-07-02

Methods and Compositions for Controlled and Sustained Production and Delivery of Peroxides and/or Oxygen for Biological and Industrial Applications

#859

20090163479

2009-06-25

USE OF TAUROLIDINE TO TREAT TUMORS

#860

20090137680

2009-05-28

NOVEL NON-SELECTIVE CATION CHANNEL IN NEURONAL CELLS AND METHOD FOR TREATING BRAIN SWELLING

#861

20090131515

2009-05-21

Combination of antidiabetic drugs

#862

20090131329

2009-05-21

Treatment for allograft rejection

#863

20090130227

2009-05-21

EXTERNAL PREPARATION FOR SKIN

#864

20090124686

2009-05-14

GSK-3 inhibitors

#865

20090118268

2009-05-07

OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS

#866

20090110746

2009-04-30

Class of therapeutics that enhance small molecule diffusion

#867

20090098210

2009-04-16

Combinations and modes of administration of therapeutic agents and combination therapy

#868

20090093526

2009-04-09

INHIBITION OF P38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS

#869

20090082435

2009-03-26

Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders

#870

20090047250

2009-02-19

Methods for treating or preventing neuroinflammation or autoimmune diseases

#871

20090041863

2009-02-12

Use of GSK3 inhibitors in combination with radiation therapies

#872

20090023793

2009-01-22

Inhibitors of melanocyte tyrosinase as topical skin lighteners

#873

20090023792

2009-01-22

Inhibitors of melanocyte tyrosinase as topical skin lighteners

#874

20090022729

2009-01-22

METHODS AND COMPOSITIONS FOR TREATING CARDIAC DYSFUNCTIONS

#875

20090018092

2009-01-15

Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids

#876

20090012161

2009-01-08

Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor

#877

20090012109

2009-01-08

Cyclopamine analogs

#878

20080318956

2008-12-25

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#879

20080312304

2008-12-18

Topical compositions containing metronidazole

#880

20080293754

2008-11-27

Cyclopamine analogs

#881

20080287515

2008-11-20

Topical compositions containing metronidazole

#882

20080287514

2008-11-20

Topical compositions containing metronidazole

#883

20080287513

2008-11-20

Topical compositions containing metronidazole

#884

20080275233

2008-11-06

Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

#885

20080261879

2008-10-23

Method of inducing and maintaining neuronal cells

#886

20080249181

2008-10-09

Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxlyamine

#887

20080249071

2008-10-09

INFLAMMATORY CYTOKINE RELEASE INHIBITOR

#888

20080241079

2008-10-02

Skin Care Products

#889

20080234233

2008-09-25

MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES

#890

20080227828

2008-09-18

Aryl Ureas With Angiogenisis Inhibiting Activity

#891

20080221215

2008-09-11

ANTIVIRAL INHIBITION OF CAPSID PROTEINS

#892

20080221105

2008-09-11

SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS

#893

20080220092

2008-09-11

Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like

#894

20080207703

2008-08-28

Antibacteriall heterocyclic ureas

#895

20080199523

2008-08-21

Particles comprising a releasable dopant therein

#896

20080194877

2008-08-14

Benzamidine Derivatives for Treatment and Prevention of Cancer Therapy Induced Mucositis

#897

20080176807

2008-07-24

Facially amphiphilic polymers and oligomers and uses thereof

#898

20080171783

2008-07-17

COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASE

#899

20080161411

2008-07-03

Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol

#900

20080153900

2008-06-26

Compositions and methods for treating or preventing imflammatory diseases